A detailed history of Avitas Wealth Management LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Avitas Wealth Management LLC holds 374 shares of REGN stock, worth $393,541. This represents 0.06% of its overall portfolio holdings.

Number of Shares
374
Previous 382 2.09%
Holding current value
$393,541
Previous $335,000 7.16%
% of portfolio
0.06%
Previous 0.06%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

SELL
$902.69 - $993.35 $7,221 - $7,946
-8 Reduced 2.09%
374 $359,000
Q4 2023

Jan 24, 2024

SELL
$775.18 - $881.7 $115,501 - $131,373
-149 Reduced 28.06%
382 $335,000
Q3 2023

Nov 02, 2023

SELL
$692.45 - $844.37 $13,156 - $16,043
-19 Reduced 3.45%
531 $436,000
Q2 2023

Jul 18, 2023

SELL
$700.03 - $830.35 $4,900 - $5,812
-7 Reduced 1.26%
550 $395,000
Q1 2023

May 15, 2023

SELL
$680.49 - $826.97 $13,609 - $16,539
-20 Reduced 3.47%
557 $457,000
Q4 2022

Jan 10, 2023

BUY
$705.89 - $766.39 $1,411 - $1,532
2 Added 0.35%
577 $0
Q3 2022

Oct 27, 2022

BUY
$573.97 - $724.32 $1,147 - $1,448
2 Added 0.35%
575 $396,000
Q2 2022

Jul 29, 2022

BUY
$548.35 - $738.84 $314,204 - $423,355
573 New
573 $339,000
Q1 2021

May 13, 2021

SELL
$446.73 - $548.2 $3.09 Million - $3.79 Million
-6,918 Closed
0 $0
Q4 2020

Feb 26, 2021

BUY
$478.3 - $607.98 $159,752 - $203,065
334 Added 5.07%
6,918 $3.34 Million
Q3 2020

Oct 06, 2020

BUY
$544.75 - $658.21 $24,513 - $29,619
45 Added 0.69%
6,584 $3.69 Million
Q2 2020

Jul 30, 2020

SELL
$493.32 - $643.92 $538,705 - $703,160
-1,092 Reduced 14.31%
6,539 $4.08 Million
Q1 2020

May 13, 2020

BUY
$336.18 - $494.43 $2.57 Million - $3.77 Million
7,631 New
7,631 $3.73 Million
Q2 2019

Jul 23, 2019

SELL
$299.6 - $414.82 $2.2 Million - $3.05 Million
-7,350 Closed
0 $0
Q1 2019

May 01, 2019

BUY
$372.08 - $439.57 $2.73 Million - $3.23 Million
7,350 New
7,350 $3.02 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $113B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Avitas Wealth Management LLC Portfolio

Follow Avitas Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avitas Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avitas Wealth Management LLC with notifications on news.